Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
Abstract Aims Spironolactone has been shown to improve outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). We investigated whether the discharge use of spironolactone could be associated with better long‐term outcomes among patients with HF with mid‐range EF (HFmrEF). M...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Oxford University Press
2020-02-01
|
| Серія: | ESC Heart Failure |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/ehf2.12571 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|